Kolon TissueGene, Inc.
A clinical-stage biopharma developing cell and gene therapies for orthopedic diseases.
950160 | KO
Overview
Corporate Details
- ISIN(s):
- KR8840120008
- LEI:
- Country:
- United States of America
- Address:
- 9713 Key West Ave Suite 300, Rockville
- Website:
- https://www.tissuegene.com/
- Sector:
- Manufacturing
Description
Kolon TissueGene, Inc. is a clinical-stage biopharmaceutical company specializing in the development of advanced cell and gene therapies for orthopedic diseases and degenerative disorders. The company's lead product candidate, TG-C, is a first-in-class, allogeneic cell and gene therapy designed to treat knee osteoarthritis. The therapy aims to reduce pain, improve joint function, and slow the progression of the disease. TG-C is currently in late-stage clinical development, undergoing Phase 3 trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-06-28 00:00 |
본점소재지변경
|
Korean | 5.3 KB | ||
| 2019-06-19 00:00 |
기타시장안내(실질심사 대상여부 결정을 위한 조사기간 연장 안내)
|
Korean | 3.2 KB | ||
| 2019-06-13 00:00 |
소송등의제기ㆍ신청(일정금액이상의청구)
|
Korean | 7.1 KB | ||
| 2019-06-05 00:00 |
대표이사변경
|
Korean | 11.7 KB | ||
| 2019-05-30 00:00 |
기타시장안내(상장적격성 실질심사 대상결정 기한 안내)
|
Korean | 3.1 KB | ||
| 2019-05-28 00:00 |
주권매매거래정지(투자자 보호)
|
Korean | 4.5 KB | ||
| 2019-05-28 00:00 |
기타시장안내(식품의약안전처의 "인보사케이주" 품목허가취소처분 관련 매매거래정지 안내)
|
Korean | 4.4 KB | ||
| 2019-05-28 00:00 |
기타시장안내(상장적격성 실질심사 관련)
|
Korean | 3.6 KB | ||
| 2019-05-28 00:00 |
주권매매거래정지기간변경(상장적격성 실질심사 대상 (사유발생))
|
Korean | 4.7 KB | ||
| 2019-05-15 00:00 |
투자판단관련주요경영사항(후속사건에 따른 2018년 재무제표 재감사에 관한 건)
|
Korean | 6.3 KB | ||
| 2019-05-15 00:00 |
분기보고서 (2019.03)
|
Korean | 1023.7 KB | ||
| 2019-05-03 00:00 |
투자판단관련주요경영사항(골관절염 세포유전자 치료제(INVOSSA) 관련 미국 FDA 공문 수령)
|
Korean | 9.7 KB | ||
| 2019-04-02 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 119.7 KB | ||
| 2019-04-01 00:00 |
투자판단관련주요경영사항(골관절염치료제 INVOSSA의 구성성분 관련 美 FDA와의 협의)
|
Korean | 7.2 KB | ||
| 2019-04-01 00:00 |
사업보고서 (2018.12)
|
Korean | 1.2 MB |
Automate Your Workflow. Get a real-time feed of all Kolon TissueGene, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kolon TissueGene, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kolon TissueGene, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
